Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study

被引:429
作者
Choi, HK
Atkinson, K
Karlson, EW
Curhan, G
机构
[1] Massachusetts Gen Hosp, Rheumatol Unit, Dept Med, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol, Cambridge, MA 02138 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Cambridge, MA 02138 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA
关键词
D O I
10.1001/archinte.165.7.742
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Limited prospective information exists on the relation between obesity,and weight change and the risk of gout. Similarly, both hypertension and diuretic use have been considered risk factors for gout; however, their independent contributions have not been established prospectively. Methods: We prospectively examined over a 12-year period (1986-1998) the relation between adiposity, weight change, hypertension, and diuretic use and incident gout in 47 150 male participants with no history of gout at baseline. We used a supplementary questionnaire to ascertain the American College of Rheumatology criteria for gout. Results: During 12 years we documented 730 confirmed incident cases of gout. Compared with men with a body mass index (BMI) of 21 to 22.9, the multivariate relative risks (RRs) of gout were 1.95 (95% confidence interval [CI], 1.44-2.65) for men with a BMI of 25 to 29.9, 2.33 (95% CI, 1.62-3.36) for men with a BMI of 30 to 34.9, and 2.97 (95% Cl, 1.73-5.10) for men with a BMI of 35 or greater (P for trend <.001). Compared with men who had maintained their weight (+/- 4 lb) since age 21 years, the multivariate RR of gout for men who had gained 30 lb or more since age 21 years was 1.99 (95% Cl, 1.49-2.66). In contrast, the multivariate RR for men who had lost 10 lb or more since the study baseline was 0.61 (95% Cl, 0.40-0.92). The multivariate RRs of gout were 2.31 (95% Cl, 1.96-2.72) for the presence of hypertension and 1.77 (95% Cl, 1.42-2.20) for diuretic use. Conclusions: Higher adiposity and weight gain are strong risk factors for gout in men, while weight loss is protective. Hypertension and diuretic use are also important independent risk factors for gout.
引用
收藏
页码:742 / 748
页数:7
相关论文
共 28 条
  • [1] GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    BRAND, FN
    KANNEL, WB
    CASTELLI, WP
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) : 237 - 242
  • [2] A PROSPECTIVE-STUDY OF NUTRITIONAL FACTORS AND HYPERTENSION AMONG UNITED-STATES MEN
    ASCHERIO, A
    RIMM, EB
    GIOVANNUCCI, EL
    COLDITZ, GA
    ROSNER, B
    WILLETT, WC
    SACKS, F
    STAMPFER, MJ
    [J]. CIRCULATION, 1992, 86 (05) : 1475 - 1484
  • [3] Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4
  • [4] Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study
    Dessein, PH
    Shipton, EA
    Stanwix, AE
    Joffe, BI
    Ramokgadi, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (07) : 539 - 543
  • [5] Hyperlipidaemia in hyperuricaemia and gout
    Emmerson, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (09) : 509 - 510
  • [6] Drug therapy - The management of gout
    Emmerson, BT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) : 445 - 451
  • [7] RELATIONSHIP BETWEEN RESISTANCE TO INSULIN-MEDIATED GLUCOSE-UPTAKE, URINARY URIC-ACID CLEARANCE, AND PLASMA URIC-ACID CONCENTRATION
    FACCHINI, F
    CHEN, YDI
    HOLLENBECK, CB
    REAVEN, GM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21): : 3008 - 3011
  • [8] Fam AG, 2002, J RHEUMATOL, V29, P1350
  • [9] Prevalence and trends in obesity among US adults, 1999-2000
    Flegal, KM
    Carroll, MD
    Ogden, CL
    Johnson, CL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14): : 1723 - 1727
  • [10] GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810